These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3051212)

  • 1. Empirical antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
    Klastersky J
    Recent Results Cancer Res; 1988; 108():53-60. PubMed ID: 3051212
    [No Abstract]   [Full Text] [Related]  

  • 2. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients. Lessons from four EORTC trials.
    Klastersky J
    Acta Oncol; 1988; 27(5):497-502. PubMed ID: 3060156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.
    Schimpff SC; Gaya H; Klastersky J; Tattersall MH; Zinner SH
    J Infect Dis; 1978 Jan; 137(1):14-29. PubMed ID: 624850
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients.
    Gaya H
    Clin Haematol; 1984 Oct; 13(3):573-86. PubMed ID: 6388933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical therapy in febrile granulocytopenic patients.
    Gaya H
    Eur J Cancer (1965); 1979; 15 Suppl():51-8. PubMed ID: 397061
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of amikacin usage in the EORTC trials.
    Zinner SH
    Am J Med; 1985 Jul; 79(1A):17-20. PubMed ID: 3895903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. A report of the EORTC International Antimicrobial Therapy Project Group.
    Gaya H
    Schweiz Med Wochenschr Suppl; 1983; 14():49-57. PubMed ID: 6361992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antimicrobial synergism in infected granulocytopenic patients.
    Standiford HC; Johnson DE; Schimpff SC
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1007-10. PubMed ID: 6540682
    [No Abstract]   [Full Text] [Related]  

  • 9. Empirical antibiotics for febrile neutropenic cancer patients.
    Hathorn JW
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
    J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
    Klastersky J; Zinner SH; Calandra T; Gaya H; Glauser MP; Meunier F; Rossi M; Schimpff SC; Tattersall M; Viscoli C
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S35-45. PubMed ID: 3280326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients.
    Gaya H; Klastersky J; Schimpff SC; Fière D; Widmaier S; Nagel G
    Eur J Cancer (1965); 1975 Aug; 11suppl():5-8. PubMed ID: 767119
    [No Abstract]   [Full Text] [Related]  

  • 13. Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia.
    Menichetti F; Bucaneve G; Patoia L; Guerciolini R; Minotti V; Pauluzzi S; Del Favero A
    Chemioterapia; 1987 Jun; 6(2 Suppl):403-5. PubMed ID: 3334584
    [No Abstract]   [Full Text] [Related]  

  • 14. The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations.
    Hann I; Noone P; Prentice HG; Sage R; Blacklock H; Stirling L; Gray R; Corringham R; Boesen E; Mohiuddin J
    J Antimicrob Chemother; 1983 May; 11 Suppl C():57-63. PubMed ID: 6352605
    [No Abstract]   [Full Text] [Related]  

  • 15. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric antibiotic therapy for granulocytopenic patients.
    Schimpff SC
    Bull N Y Acad Med; 1982 Nov; 58(8):750-6. PubMed ID: 6963185
    [No Abstract]   [Full Text] [Related]  

  • 17. Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy.
    Sculier JP; Weerts D; Klastersky J
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):55-60. PubMed ID: 6537916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric antibiotic treatment of infections in myelosuppressed cancer patients. Preliminary results.
    Hellriegel KP; Kindler J; Wittenberg C; Kress M
    Infection; 1982; 10 Suppl 3():S138-40. PubMed ID: 6218101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical antimicrobial therapy in the neutropenic host.
    Young LS
    N Engl J Med; 1986 Aug; 315(9):580-1. PubMed ID: 3526156
    [No Abstract]   [Full Text] [Related]  

  • 20. Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.
    Hathorn JW; Rubin M; Pizzo PA
    Antimicrob Agents Chemother; 1987 Jul; 31(7):971-7. PubMed ID: 3310871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.